Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse Seeks FDA OK for New Flu Assay

NEW YORK (GenomeWeb News) – Prodesse today said that it has filed for US Food and Drug Administration 510(k) clearance of its ProParaflu+ assay.

The RT-PCR assay has been developed to rapidly detect and differentiate parainfluenza viruses 1, 2 and 3. The Milwaukee, Wis.-based firm said that the new assay is its third respiratory and fourth overall real-time assay that has been submitted for FDA clearance.

"Along with ProFlu+ and Pro hMPV+ these three respiratory products with their seven detections share an internal control allowing clinicians to easily run the most appropriate series of tests for their patients from just a single nucleic acid extraction," Karen Harrington, who oversaw clinical trials for Prodesse, said in a statement.

Prodesse said that ProParaflu+ can provide results within three hours as opposed to up to several days for current methods that don't use RT-PCR.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.